Patents by Inventor William Carroll

William Carroll has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • P2X7 antagonists for treating neuropathic pain
    Publication number: 20050171195
    Abstract: The present invention discloses a method for treating neuropathic pain using compounds of formula I or compositions containing compounds of formula I.
    Type: Application
    Filed: November 3, 2004
    Publication date: August 4, 2005
    Inventors: William Carroll, Arturo Medrano, Michael Jarvis, Ying Wang, Sridhar Peddi
  • Composition for increasing cellulosic product strength and method of increasing cellulosic product strength
    Publication number: 20050082025
    Abstract: A composition includes water; at least one hydrophilic polymer containing at least two groups which are independently the same or different a primary amine group or a secondary amine group and at least one saccharide containing a reducible function as described above. The hydrophilic polymer and the saccharide are mixed to form a reaction mixture and reacted to increase the viscosity of the reaction mixture. The reaction is then substantially terminated by reducing the pH of the composition.
    Type: Application
    Filed: March 12, 2004
    Publication date: April 21, 2005
    Inventors: William Carroll, Christian Rendu, Eric Beckman
  • Synthesis of N-vinyl formamide
    Publication number: 20050033089
    Abstract: A process to produce N-vinylformamide includes the steps of: reacting hydroxyethyl formamide with a reactant comprising at least one cyclic anhydride group to form an ester, and dissociating the ester via heat in a thin film evaporation to synthesize N-vinylformamide and a compound comprising at least one diacid group, the N-vinylformamide separating from the diacid during the thin film evaporation. The reactant including at least one cyclic anhydride group can, for example, be succinic anhydride, maleic anhydride, phthalic anhydride, (2-docecen-1-yl)succinic anhydride, exo-3,6-epoxy-1,2,3,6 -tetrahydrophthalic anhydride or a polymer including at least one cyclic anhydride group.
    Type: Application
    Filed: February 27, 2004
    Publication date: February 10, 2005
    Inventors: Eric Beckman, Toby Chapman, Cedrick Favero, Christopher Capelli, Harold Swift, William Carroll
  • Tumor targeted vector
    Patent number: 6852703
    Abstract: A vector comprising a nucleotide sequence of interest (“NOI”) encoding a product of interest (“POI”) is described. The NOI and/or the POI is capable of recognizing a tumor, such that in use the vector is capable of delivering the NOI and/or the POI to the tumor.
    Type: Grant
    Filed: June 4, 1998
    Date of Patent: February 8, 2005
    Assignee: Oxford Biomedica (UK) Limited
    Inventors: Susan Mary Kingsman, Christopher Robert Bebbington, Fiona Margaret Ellard, Miles William Carroll, Kevin Alan Myers
  • Methods for identifying differentially expressed genes by multivariate analysis of microaaray data
    Publication number: 20040265830
    Abstract: The present invention applies pattern recognition and multidimensional classification in statistical microarray data analysis. There are provided methods for identifying a subset of genes that are differentially expressed under a given biological state or at a given biological locale of interest by determining an advantageously large probability distance between the random vectors representing expression levels of the genes of interest. The invention also provides a cross-validated random search mechanism for a subset of genes based on various probability distances between two random vectors.
    Type: Application
    Filed: August 18, 2004
    Publication date: December 30, 2004
    Inventors: Aniko Szabo, Alexander Tsodikov, Andrei Yakovlev, Kenneth Boucher, David A. Jones, William Carroll
  • Polypeptide
    Publication number: 20040265275
    Abstract: The present invention provides 5T4 tumour-associated antigen (TAA) for use in a method of immunotherapy of tumours. The invention also relates to a recombinant poxvirus vector from which at least one immune evasion gene has been deleted, which comprises a nucleic acid sequence encoding a 5T4 TAA and the use thereof in vaccinating against and in treating tumours.
    Type: Application
    Filed: February 6, 2004
    Publication date: December 30, 2004
    Applicant: Oxford BioMedica (UK) Limited
    Inventors: Miles William Carroll, Kevin Alan Myers
  • Mobile collection application
    Publication number: 20040203668
    Abstract: A mobile collection application is disclosed that is capable of providing collection data to a field agent on a wireless pocket PC. A collection case inventory module is used to generate a list of collection cases on the wireless pocket PC. The field agent may view a detailed report of collection cases that are contained in the list of collection cases. A payment plan component is also provided that allows the field agent to work out a payment plan with the debtor. The mobile collection application is also capable of allowing field agents to register transient taxpayers for the purpose of collecting sales and use taxes.
    Type: Application
    Filed: March 18, 2003
    Publication date: October 14, 2004
    Inventors: Jeffrey C. Bowne, Joseph A. Milack, Jay William Carroll
  • Pyrrolopyridine potassium channel openers
    Publication number: 20040192697
    Abstract: Novel pyrrolopyridine compounds of formula (I), 1
    Type: Application
    Filed: December 18, 2003
    Publication date: September 30, 2004
    Inventors: Sean C. Turner, Tammie K. White, William A. Carroll
  • Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
    Patent number: 6780872
    Abstract: Compounds of formula I are useful in treating diseases prevented by or ameliorated with potassium channel openers. Also disclosed are potassium channel opening compositions and a method of opening potassium channels in a mammal.
    Type: Grant
    Filed: January 22, 2003
    Date of Patent: August 24, 2004
    Assignee: Abbott Laboratories
    Inventors: Irene Drizin, Robert J. Altenbach, William A. Carroll
  • Vector system
    Publication number: 20040131591
    Abstract: The present invention provides a vector system comprising a nucleotide sequence coding for an antibody. In particular, the present invention relates to the use of such a vector system in a subject, where the nucleotide sequence is expressed in vivo to produce said antibody.
    Type: Application
    Filed: December 30, 2002
    Publication date: July 8, 2004
    Inventors: Alan John Kingsman, Christopher Robert Bebbington, Miles William Carroll, Fiona Margaret Ellard, Susan Mary Kingsman, Kevin Alan Myers, Abigail Lamikanra
  • Pyrrolopyridine potassium channel openers
    Publication number: 20040122218
    Abstract: Novel pyrrolopyridine compounds of formula (I), 1
    Type: Application
    Filed: December 20, 2002
    Publication date: June 24, 2004
    Inventors: Sean Turner, Tammie White, William A. Carroll
  • Potassium channel openers
    Patent number: 6645968
    Abstract: Compounds of formula I: are useful in treating diseases prevented by or ameliorated with potassium channel openers. Also disclosed are potassium channel opening compositions and a method of opening potassium channels in a mammal.
    Type: Grant
    Filed: February 5, 2001
    Date of Patent: November 11, 2003
    Assignee: Abbott Laboratories
    Inventors: Robert J. Altenbach, Hao Bai, Jorge D. Brioni, William A. Carroll, Murali Gopalakrishnan, Robert J. Gregg, Mark W. Holladay, Peggy P. Huang, John F. Kincaid, Michael E. Kort, Philip R. Kym, John K. Lynch, Arturo Perez-Medrano, Henry Q. Zhang
  • Pyrano, piperidino, and thiopyrano compounds and methods of use
    Patent number: 6642222
    Abstract: The present invention provides novel compounds of formula I which may be useful in hyperpolarizing cell membranes, opening potassium channels, relaxing smooth muscle cells, and inhibiting bladder contractions.
    Type: Grant
    Filed: May 3, 2000
    Date of Patent: November 4, 2003
    Assignee: Abbott Laboratories
    Inventors: William A. Carroll, Konstantinos A. Agrios, Robert J. Altenbach, Irene Drizin, Michael E. Kort
  • Naphthalene amides as potassium channel openers
    Publication number: 20030199578
    Abstract: The present invention relates to compounds and their ability to act as potassium channel openers.
    Type: Application
    Filed: April 19, 2002
    Publication date: October 23, 2003
    Inventors: Sean C. Turner, Neil A. Castle, William A. Carroll, Tammie K. White
  • Radioligands and their use for identifying potassium channel modulators
    Patent number: 6632418
    Abstract: The present invention relates to novel radioligands and test methods using those radioligands in screening compounds.
    Type: Grant
    Filed: July 30, 2002
    Date of Patent: October 14, 2003
    Assignee: Abbott Laboratories
    Inventors: Robert J. Altenbach, Gary A. Rotert, William A. Carroll, Murali Gopalakrishnan, Eduardo Jose Vicente Molinari, Rachel A. Davis-Taber, Victoria Eleanor Sarah Scott
  • Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
    Publication number: 20030171394
    Abstract: Compounds of formula I 1
    Type: Application
    Filed: January 22, 2003
    Publication date: September 11, 2003
    Inventors: Irene Drizin, Robert J. Altenbach, William A. Carroll
  • Retroviral vectors
    Publication number: 20030147907
    Abstract: A retroviral vector derived from a non-primate lentivirus genome comprising a deleted gag gene wherein the deletion in gag removes one or more nucleotides downstream of nucleotide 350 of the gag coding sequence.
    Type: Application
    Filed: May 29, 2001
    Publication date: August 7, 2003
    Inventors: Alan John Kingsman, Miles William Carroll, Jonathan Rohll, Kyriacos Mitrophanous, Narry Kim
  • Potassium channel openers
    Patent number: 6593335
    Abstract: Compounds having the formula I: are useful in treating diseases prevented by or ameliorated with potassium channel openers. Also disclosed are potassium channel opening compositions and a method of opening potassium channels in a mammal.
    Type: Grant
    Filed: June 23, 1999
    Date of Patent: July 15, 2003
    Assignee: Abbott Laboratories
    Inventors: William A. Carroll, Yiyuan Chen, Mark W. Holladay, Michael E. Kort, Philip R. Kym, James P. Sullivan, Rui Tang, Lin Yi, Henry Q. Zhang, Irene Drizin
  • 4-Imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use
    Publication number: 20030073850
    Abstract: Compounds of formula I 1
    Type: Application
    Filed: February 17, 2000
    Publication date: April 17, 2003
    Inventors: Robert J. Altenbach, Michael D. Meyer, James F. Kerwin, Albert Khilevich, Teodozyj Kolasa, Jeffrey Rohde, William A. Carroll, Xenia Searle, Fan Yang
  • Novel radioligands and their use for identifying potassium channel modulators
    Publication number: 20030065182
    Abstract: The present invention relates to novel radioligands and test methods using those radioligands in screening compounds.
    Type: Application
    Filed: July 30, 2002
    Publication date: April 3, 2003
    Inventors: Robert J. Altenbach, Gary A. Rotert, William A. Carroll, Murali Gopalakrishnan, Eduardo Jose Vicente Molinari, Rachel A. Davis-Taber, Victoria Eleanor Sarah Scott